Biblio Discovery — Demo Discovery Service

656 hasil

Menampilkan 1–20 · 1,03 detik · RSS

Jurnal

Therapeutic Advances in Endocrinology and Metabolism

Scopus

ISSN 2042-0188 · SAGE Publishing · 656 artikel di indeks

  1. Artikel Jurnal

    Metabolic effects of GLP-1 and GLP-2 across fed, fasting, and starvation states: A systematic review with structured narrative synthesis

    Aime Patrick Niyomugabo; Leopold Ntakirutimana; Pelagie Izabayo dkk.

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 19 · 2026 · Inggris · DOAJ Scopus

    Background GLP-1 and GLP-2 are co-secreted gut-derived peptides that regulate glucose homeostasis, appetite, nutrient handling, and intestinal adaptation. Their physiological effects vary across nutritional states, with evidence strongest for the fed (postprandial) state and remaining limited for…

  2. Artikel Jurnal

    Systematic review and network meta-analysis of the safety and efficacy of the triple incretin receptor agonist, retatrutide compared to the dual incretin receptor agonist, tirzepatide, for treatment of type 2 diabetes mellitus

    Anastasia Tereshchenko; Belén Garay Gálvez; Javier Ananda Tello

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 19 · 2026 · Inggris · DOAJ Scopus

    Background Type 2 diabetes mellitus (T2DM) is a common metabolic disorder marked by persistent hyperglycaemia that requires effective treatment to prevent complications. As current therapies do not achieve adequate glycaemic control in all patients, the triple receptor agonist retatrutide was…

  3. Artikel Jurnal

    The uric acid-to-homocysteine ratio as a prognostic marker for all-cause and cardiovascular mortality: A national population-based study

    Chao Xuan MD, PhD; Ting-Ting Zhou MD, PhD; Jun-Jie Guo MD, PhD dkk.

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 19 · 2026 · Inggris · DOAJ Scopus

    Background The homocysteine (Hcy) paradox, the failure of Hcy-lowering therapies to consistently reduce cardiovascular events, remains a major challenge in metabolic medicine. We hypothesize that adenosine (Ado), a stoichiometric byproduct of Hcy production with vascular protective effects, may be…

  4. Artikel Jurnal

    Impact of training type (virtual vs in-person) on long-term glycemic control in people with type 1 diabetes using minimed 780: A non-inferiority longitudinal study

    Ana María Gómez Medina; Diana Cristina Henao-Carrillo; Oscar Muñoz dkk.

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 19 · 2026 · Inggris · DOAJ Scopus

    Background Information on the long-term effect of a virtual educational program compared to in-person training for advanced closed-loop hybrid (AHCL) system users is limited. Objective To evaluate whether virtual training is no inferior to face-to-face training with respect to long-term glycemic…

  5. Artikel Jurnal

    Serum testosterone and uric acid: Key biomarkers for predicting response to drospirenone/ethinyl estradiol tablets (II) in adolescents polycystic ovary syndrome

    Xuyong Chen; Yuanyuan Teng; Yue He dkk.

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 19 · 2026 · Inggris · DOAJ Scopus

    Background Adolescent polycystic ovary syndrome (PCOS) poses diagnostic and management challenges. Although combined oral contraceptives (COCs) can improve symptoms, treatment response varies. Objectives To evaluate the efficacy of drospirenone/ethinyl estradiol tablets (II) (DRSP/EE (II)) and…

  6. Artikel Jurnal

    Associations of mortality and sepsis after GLP-1 receptor agonist initiation versus SGLT2 inhibitor or metformin initiation in people with HIV, overweight or obesity, and type 2 diabetes: A target trial emulation

    Yu-Nan Huang PhD; Pei-Yun Li MPH; Kai-Wen Liu MS dkk.

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 19 · 2026 · Inggris · DOAJ Scopus

    Background People living with HIV (PLWH) with overweight or obesity and type 2 diabetes (T2D) carry elevated cardiometabolic and infectious morbidity. Comparative effectiveness data for glucagon-like peptide-1 receptor agonists (GLP-1 RAs)against active comparators are scarce in this population…

  7. Artikel Jurnal

    Dietary protein content and its impact on amino acid profile and appetite in patients with methylmalonic acidemia

    Engin Köse MD; Neslihan Doğulu MD; Furkan Yolcu RD dkk.

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 19 · 2026 · Inggris · DOAJ Scopus

    Background Medical formulas used in the dietary management of methylmalonic acidemia (MMA) are typically enriched in leucine and may contribute to branched-chain amino acid imbalance and appetite suppression. However, the relationship between dietary protein composition, circulating leucine levels…

  8. Artikel Jurnal

    Prospective multicenter evaluation of glycemic and patient-reported outcomes following transition to a next-generation continuous glucose monitoring system in users of advanced hybrid closed-loop technology

    Lía Nattero-Chávez; Mar Lorenzo; María Soledad Ruiz de Adana dkk.

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 17 · 2026 · Inggris · DOAJ Scopus

    Aims: To assess the real-world impact of transitioning from the Dexcom G6 ® to G7 ® system in individuals with type 1 diabetes (T1D) using the Tandem t:slim X2™ with Control-IQ™. Primary outcomes included glycemic control changes, while secondary outcomes evaluated patient-reported outcomes (PROMs)…

  9. Artikel Jurnal

    Association of prediabetes phenotypes with metabolic dysfunction-associated fatty liver disease and liver fibrosis: a population-based study

    Miao He; Yan Liu; Tianyun Gao dkk.

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 17 · 2026 · Inggris · DOAJ Scopus

    Background: Prediabetes comprises three heterogeneous glucometabolic phenotypes and is associated with an increased risk of metabolic dysfunction-associated fatty liver disease (MAFLD). However, the association of different prediabetes phenotypes with the presence of MAFLD and liver fibrosis…

  10. Artikel Jurnal

    Association between the ratio of uric acid to high-density lipoprotein cholesterol (UHR) and the abnormal risk of sarcopenia: Evidence from two large population-based surveys and interpretable machine learning-driven sarcopenia screening

    Yunnong Luo; Aisheng Wang; Minfei Wu dkk.

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 19 · 2026 · Inggris · DOAJ Scopus

    Background Sarcopenia is a geriatric syndrome linked to nutritional intake, chronic inflammation and metabolic dysregulation. While uric acid (UA) and high-density lipoprotein cholesterol (HDL-C) are recognized biomarkers, their specific relationship with sarcopenia remains debated. The uric…

  11. Artikel Jurnal

    Hashimoto’s thyroiditis and ablation-zone involution after microwave ablation for low-risk papillary thyroid carcinoma: An overlap-weighted cohort study

    Song Li MD; Ying Wei MD; Zhen-long Zhao MD dkk.

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 19 · 2026 · Inggris · DOAJ Scopus

    Background Microwave ablation (MWA) is increasingly used for selected low-risk papillary thyroid carcinoma (PTC), but the influence of coexisting Hashimoto’s thyroiditis (HT) on post-ablation imaging involution remains unclear. Objectives To determine whether coexisting HT independently alters…

  12. Artikel Jurnal

    Assessing the quality and reliability of health information on GLP-1 receptor agonists on TikTok and Bilibili: a cross-sectional analysis of the public health infodemic

    Gang Peng; Chen Wang; Hong-Wei Zhang dkk.

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 17 · 2026 · Inggris · DOAJ Scopus

    Background: Glucagon-like peptide-1 (GLP-1) receptor agonists have transitioned from clinical tools for diabetes to a global cultural phenomenon for weight loss, triggering an “infodemic.” While previous studies have characterized this landscape on Western platforms, the digital health ecosystem in…

  13. Artikel Jurnal

    Association between HOMA-IR and coexisting MASLD and type 2 diabetes: Insights from NHANES and network pharmacology

    Xian-Pei Heng; Liu-Qing Yang; Qi-Wei Chen dkk.

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 19 · 2026 · Inggris · DOAJ Scopus

    Background Insulin resistance is a common metabolic feature of metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes (T2D), but its cross-sectional association with the coexistence of these conditions remains incompletely characterized. Objectives To evaluate the…

  14. Artikel Jurnal

    Glucose-lowering therapy in diabetes of the exocrine pancreas: a real-world evidence analysis in a tertiary hospital in the timeframe 2018–2022

    Gea Ciccarelli; Nicoletta Di Giorgi; Chiara Iacomini dkk.

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 17 · 2026 · Inggris · DOAJ Scopus

    Background: Diabetes of the exocrine pancreas (DEP) is a form of diabetes that arises in the presence of an exocrine pancreas disease and is mainly associated with acute and chronic pancreatitis. Therapeutic management of DEP has not changed over the past decades, and treatment is mostly insulin…

  15. Artikel Jurnal

    From traditional to novel: a national cohort study on the predictive value of C-reactive protein–triglyceride–glucose-obesity composite parameters for cardiovascular disease

    Mengjie Zhao; Xujie Wang; Xuexue Zhang dkk.

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 17 · 2026 · Inggris · DOAJ Scopus

    Background: Cardiovascular disease (CVD) is the leading cause of mortality worldwide. The C-reactive protein–triglyceride–glucose (CTI) index captures metabolic inflammation and insulin resistance, while obesity indices reflect adiposity-related cardiometabolic risk. However, the predictive value…

  16. Artikel Jurnal

    Global burden of gout attributable to high BMI (1990–2021) and causal link with obesity: a GBD and Mendelian randomization study

    Baofeng Wu; Ziang Liu; Zekai Chen dkk.

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 17 · 2026 · Inggris · DOAJ Scopus

    Background: High body mass index (BMI ⩾25 kg/m 2 ) is a critical driver of the global gout epidemic. We aimed to characterize the evolving burden of gout attributable to high BMI and establish the potential causal links between varying obesity grades and gout risk. Objectives: We aimed to…